Page last updated: 2024-12-08

kw 5805

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

KW 5805: structure given in first source; RN given refers to (+)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID175662
MeSH IDM0156058

Synonyms (10)

Synonym
5-((2-(diethylamino)ethyl)amino)-5,11-dihydro(1)-benzoxepino(3,4-b)pyridine
1,2-ethanediamine, n'-(5,11-dihydro(1)benzoxepino(3,4-b)pyridin-5-yl)-n,n-diethyl-, trihydrochloride, (+)-
kw-5805
1,2-ethanediamine, n,n-diethyl-n'-(5,11-dihydro(1)benzoxepino(3,4-b)pyridin-5-yl)-, hydrochloride, hydrate (1:3:1)
kw 5805
5-(2-(diethylamino)ethyl)amino-5,11-dihydro(1)-benzoxepino(3,4-b)pyridine trihydrochloride
95968-62-0
n~2~-(5,11-dihydro[1]benzoxepino[3,4-b]pyridin-5-yl)-n~1~,n~1~-diethylethane-1,2-diamine--hydrogen chloride (1/3)
DTXSID70914721
n-(5,11-dihydro-[1]benzoxepino[3,4-b]pyridin-11-yl)-n',n'-diethylethane-1,2-diamine;trihydrochloride
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (42.86)18.7374
1990's4 (57.14)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (14.29%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (85.71%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]